[1]
“Comparative Outcome of Oral and Subcutaneous Methotrexate Therapy in Children with Juvenile Idiopathic Arthritis”, Ibrahim card. med. j., vol. 5, no. 1-2, pp. 27–34, Apr. 2017, doi: 10.3329/icmj.v5i1-2.53699.